Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
442.73
+10.21 (2.36%)
At close: Aug 14, 2025, 4:00 PM
445.00
+2.27 (0.51%)
After-hours: Aug 14, 2025, 7:17 PM EDT
Alnylam Pharmaceuticals (ALNY) Revenue by Segment
History
Date | Amvuttra | Givlaari | Collaboration | Onpattro | Oxlumo | Royalty |
---|---|---|---|---|---|---|
Jun 30, 2025 | 1.35B | 283.46M | 325.03M | 208.43M | 172.73M | 125.23M |
Mar 31, 2025 | 1.09B | 264.71M | 490.83M | 233.09M | 166.46M | 107.65M |
Dec 31, 2024 | 970.41M | 255.85M | 510.15M | 252.80M | 166.97M | 91.79M |
Sep 30, 2024 | 859.20M | 250.50M | 479.60M | 275.70M | 156.10M | 73.40M |
Jun 30, 2024 | 749.30M | 233.60M | 849.70M | 307.00M | 144.60M | 59.90M |
Mar 31, 2024 | 651.30M | 229.40M | 628.20M | 321.30M | 128.20M | 44.70M |
Dec 31, 2023 | 557.90M | 219.20M | 546.20M | 354.60M | 109.80M | 40.60M |
Sep 30, 2023 | 451.20M | 207.00M | 540.40M | 397.80M | 100.90M | 26.30M |
Jun 30, 2023 | 327.70M | 198.60M | 142.20M | 461.20M | 88.60M | 19.10M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.